Lundbeck Biotech Incubator

Supporting emerging early-stage biotech companies

The incubator aims to support and accelerate drug discovery and new technologies within brain diseases and to promote a culture of innovation and entrepreneurship within the Danish and European ecosystem. Lundbeck offers access to state-of-the-art facilities and decades of experience in medicine design for brain diseases.

Lundbeck´s Biotech Incubator targets scientists, innovators, and entrepreneurs in early-stage biotechnology companies. With a dedicated space to support and nurture promising innovative startups, Lundbeck is enhancing its partnerships and visibility within Denmark's thriving life science and biotech industry. The inaugural participant is actively engaged, working side by side with Lundbeck researchers in a fully integrated incubator model. 

"The Lundbeck Biotech Incubator is part of a larger push towards embracing more innovative ways of working and enhancing our visibility as an attractive partner within the biotech community. The model is tailored to enable and accelerate innovative and translational science that fosters drug discovery." Tarek Samad, Senior Vice President & Global Head of Research, Corporate Patents & Trademarks

Are you interested in learning more? Get in touch

Bettina Laursen, PhD

Head of Operations

Lundbeck Biotech Incubator


Jesper Frank Bastlund, PhD

Head of Strategy

Lundbeck Biotech Incubator


More from Lundbeck

Our Position on Brain Health

What brain health means to us at Lundbeck.

Our Science

Lundbeck has developed some of the world’s most widely prescribed therapies.


True stories from patients and carers, our employees, and scientists.